Other Potential Targets in Melanoma: Clinical Perspective

Other Potential Targets in Melanoma: Clinical Perspective

In this CME activity, Dr. Paolo Ascierto provides an update on the latest …

Expiration Date: 12/7/2017

Max Credits: 0

View Activity

NSCLC Treatment on Target: Examining New Evidence and Advances

NSCLC Treatment on Target: Examining New Evidence and Advances

Globally, lung cancer is the leading cause of cancer-related deaths. Eight…

Expiration Date: 12/15/2016

Max Credits: 0

View Activity

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 12/14/2016

Max Credits: 0

View Activity

Leveraging Technologies for Melanoma Screening and Diagnosis

Leveraging Technologies for Melanoma Screening and Diagnosis

在这个CME活动,阿什法克博士。Marghoob provides an update on the tec…

Expiration Date: 11/14/2017

Max Credits: 0

View Activity

BRAF/MEK Combination Therapy in Melanoma: Current Status

BRAF/MEK Combination Therapy in Melanoma: Current Status

In this CME activity, Dr. Axel Hauschild provides an update on the BRAF/ME…

Expiration Date: 12/8/2016

Max Credits: 0

View Activity

Envisioning the Future of Melanoma Diagnosis Through the Lens of Medical Informatics

Envisioning the Future of Melanoma Diagnosis Through the Lens of Medical Informatics

In this CME activity, Dr. Stephen Q. Wang, MD, discusses medical informati…

Expiration Date: 11/22/2016

Max Credits: 0

View Activity

Sequencing Targeted Therapy and Immunotherapy for Patients with Metastatic BRAFV600 Mutant Melanoma: How are We Going to Figure it Out?

Sequencing Targeted Therapy and Immunotherapy for Patients with Metastatic BRAFV600 Mutant Melanoma: How are We Going to Figure it Out?

Metastatic melanoma is one of the most challenging malignancies to treat. …

Expiration Date: 11/11/2016

Max Credits: 0

View Activity

NSCLC Treatment on Target: Examining New Evidence and Advances

NSCLC Treatment on Target: Examining New Evidence and Advances

Globally, lung cancer is the leading cause of cancer-related deaths. Eight…

Expiration Date: 11/9/2016

Max Credits: 0

View Activity

Ipilimumab versus Placebo After Complete Resection of Stage III Melanoma: Results from the EORTC 18071 Phase III Trial

Ipilimumab versus Placebo After Complete Resection of Stage III Melanoma: Results from the EORTC 18071 Phase III Trial

In this CME activity, Dr. Alexander Eggermont discusses the EORTC 18071 ph…

Expiration Date: 11/5/2016

Max Credits: 0

View Activity

Systemic Management of Brain Metastases

Systemic Management of Brain Metastases

Brain metastases in metastatic melanoma are highly prevalent and are assoc…

Expiration Date: 11/3/2016

Max Credits: 0

View Activity